FoxP3+ regulatory T cells restrain splenic extramedullary myelopoiesis via suppression of hemopoietic cytokine-producing T cells

Journal of Immunology

Volumn 183, Issue 10, 2009, Pages 6377-6386

  Lee, Jee H ^a   Wang, Chuanwu ^a   Kim, Chang H ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CELL CONTACT; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; EXTRAMEDULLARY HEMATOPOIESIS; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSTIMULATION; INFECTION; INFLAMMATION; INFLAMMATORY DISEASE; LYMPHOCYTE DIFFERENTIATION; MOUSE; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN; T LYMPHOCYTE;

ANIMALS; BONE MARROW; FORKHEAD TRANSCRIPTION FACTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERLEUKIN-3; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED BALB C; MYELOPOIESIS; SIGNAL TRANSDUCTION; SPLEEN; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 77954235684     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901268     Document Type: Article

References (54)

1. Cumano, A., and I. Godin. 2007. Ontogeny of the hematopoietic system. Annu. Rev. Immunol. 25: 745-785.
2. Heissig, B., Y. Ohki, Y. Sato, S. Rafii, Z. Werb, and K. Hattori. 2005. A role for niches in hematopoietic cell development. Hematology 10: 247-253.
3. Spencer, R. P., and H. A. Pearson. 1975. The spleen as a hematological organ. Semin. Nucl. Med. 5: 95-102.
4. Cumano, A., F. Dieterlen-Lievre, and I. Godin. 1996. Lymphoid potential, probed before circulation in mouse, is restricted to caudal intraembryonic splanchnopleura. Cell 86: 907-916.
5. Brigden, M. L. 1993. Overwhelming postsplenectomy infection. West J. Med. 158: 308-309.
6. Sills, R. H. 1987. Splenic function: physiology and splenic hypofunction. Crit. Rev. Oncol. Hematol. 7: 1-36.
7. Suzuki, H., T. M. Kundig, C. Furlonger, A. Wakeham, E. Timms, T. Matsuyama, R. Schmits, J. J. Simard, P. S. Ohashi, H. Griesser, et al. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 268: 1472-1476.
8. Murray, P. J., R. A. Young, and G. Q. Daley. 1998. Hematopoietic remodeling in interferon-γ-deficient mice infected with mycobacteria. Blood 91: 2914-2924.
9. Arellano-Rodrigo, E., J. Esteve, E. Gine, J. Panes, and F. Cervantes. 2002. Idiopathic myelofibrosis associated with ulcerative colitis. Leuk. Lymphoma 43: 1481-1483. (Pubitemid 34705036)
10. Ostrand-Rosenberg, S., and P. Sinha. 2009. Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 182: 4499-4506.
11. Laiosa, C. V., M. Stadtfeld, and T. Graf. 2006. Determinants of lymphoid-myeloid lineage diversification. Ann. Rev. Immunol. 24: 705-738.
12. Kaushansky, K. 2006. Lineage-specific hematopoietic growth factors. N. Engl. Med. 354: 2034-2045.
13. Nishimoto, N., and T. Kishimoto. 2006. Interleukin 6: from bench to bedside. Nat. Clin. Pract. 2: 619-626.
14. Barreda, D. R., P. C. Hanington, and M. Belosevic. 2004. Regulation of myeloid development and function by colony stimulating factors. Dev. Comp. Immunol. 28: 509-554.
15. Broxmeyer, H. E. 2008. Chemokines in hematopoiesis. Curr. Opin. Hematol. 15: 49-58.
16. Garland, J. M. 1990. Lymphocytes, lymphokines, and hematopoiesis. Immunol. Ser. 49: 297-328.
17. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136: 2348-2357.
18. Kelso, A., and T. Owens. 1988. Production of two hemopoietic growth factors is differentially regulated in single T lymphocytes activated with an anti-T cell receptor antibody. J. Immunol. 140: 1159-1167. (Pubitemid 18088583)
19. Wierenga, E. A., B. Backx, M. Snoek, L. Koenderman, and M. L. Kapsenberg. 1993. Relative contributions of human types 1 and 2 T-helper cell-derived eosinophilotrophic cytokines to development of eosinophilia. Blood 82: 1471-1479.
20. Broxmeyer, H. E., S. Sehra, S. Cooper, L. M. Toney, S. Kusam, J. J. Aloor, C. C. Marchal, M. C. Dinauer, and A. L. Dent. 2007. Aberrant regulation of hematopoiesis by T cells in BAZF-deficient mice. Mol. Cell. Biol. 27: 5275-5285.
21. + T cells. Blood 105: 1484-1491.
22. + regulatory T cells. Immunol. Rev. 212: 60-73.
23. Zheng, Y., and A. Y. Rudensky. 2007. Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 8: 457-462.
24. + regulatory T cells in self-tolerance and autoimmune disease. Curr. Top. Microbiol. Immunol. 305: 51-66.
25. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188: 287-296.
26. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 30: 1538-1543.
27. + regulatory T cells suppress NKT cell functions. Cancer Res. 63: 4516-4520.
28. + regulatory T cells. Hum. Immunol. 66: 222-230.
29. + regulatory T cells. J. Immunol. 175: 4180-4183.
30. + self-reactive T cells. J. Immunol. 180: 4679-4686.
31. + natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. USA 105: 10113-10118.
32. Wildin, R. S., F. Ramsdell, J. Peake, F. Faravelli, J. L. Casanova, N. Buist, E. Levy-Lahad, M. Mazzella, O. Goulet, L. Perroni, et al. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27: 18-20.
33. Brunkow, M. E., E. W. Jeffery, K. A. Hjerrild, B. Paeper, L. B. Clark, S. A. Yasayko, J. E. Wilkinson, D. Galas, S. F. Ziegler, and F. Ramsdell. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27: 68-73.
34. Bennett, C. L., J. Christie, F. Ramsdell, M. E. Brunkow, P. J. Ferguson, L. Whitesell, T. E. Kelly, F. T. Saulsbury, P. F. Chance, and H. D. Ochs. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27: 20-21.
35. Lin, W., N. Truong, W. J. Grossman, D. Haribhai, C. B. Williams, J. Wang, M. G. Martin, and T. A. Chatila. 2005. Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice. J. Allergy Clin. Immunol. 116: 1106-1115.
36. Lyon, M. F., J. Peters, P. H. Glenister, S. Ball, and E. Wright. 1990. The scurfy mouse mutant has previously unrecognized hematological abnormalities and resembles Wiskott-Aldrich syndrome. Proc. Natl. Acad. Sci. USA 87: 2433-2437.
37. Clark, L. B., M. W. Appleby, M. E. Brunkow, J. E. Wilkinson, S. F. Ziegler, and F. Ramsdell. 1999. Cellular and molecular characterization of the scurfy mouse mutant. J. Immunol. 162: 2546-2554.
38. Dranoff, G., A. D. Crawford, M. Sadelain, B. Ream, A. Rashid, R. T. Bronson, G. R. Dickersin, C. J. Bachurski, E. L. Mark, J. A. Whitsett, et al. 1994. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264: 713-716.
39. Kim, C. H., C. K. Qu, G. Hangoc, S. Cooper, N. Anzai, G. S. Feng, and H. E. Broxmeyer. 1999. Abnormal chemokine-induced responses of immature and mature hematopoietic cells from motheaten mice implicate the protein tyrosine phosphatase SHP-1 in chemokine responses. J. Exp. Med. 190: 681-690.
40. Godfrey, V. L., J. E. Wilkinson, and L. B. Russell. 1991. X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am. J. Pathol. 138: 1379-1387.
41. Scherer, M. T., L. Ignatowicz, G. M. Winslow, J. W. Kappler, and P. Marrack. 1993. Superantigens: bacterial and viral proteins that manipulate the immune system. Annu. Rev. Cell Biol. 9: 101-128.
42. + regulatory T cells is mediated by cell surfacebound transforming growth factor β. J. Exp. Med. 194: 629-644.
43. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness. J. Exp. Med. 196: 237-246.
44. Gorelik, L., and R. A. Flavell. 2000. Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12: 171-181. (Pubitemid 30398631)
45. + T cells undergo conventional first switch to lymphoid tissue homing receptors in thymus but accelerated second switch to nonlymphoid tissue homing receptors in secondary lymphoid tissues. J. Immunol. 178: 301-311.
46. Biondo, M., Z. Nasa, A. Marshall, B. H. Toh, and F. Alderuccio. 2001. Local transgenic expression of granulocyte macrophage-colony stimulating factor initiates autoimmunity. J. Immunol. 166: 2090-2099. (Pubitemid 32114699)
47. Lang, R. A., D. Metcalf, R. A. Cuthbertson, I. Lyons, E. Stanley, A. Kelso, G. Kannourakis, D. J. Williamson, G. K. Klintworth, T. J. Gonda, et al. 1987. Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage. Cell 51: 675-686.
48. Stanley, E., G. J. Lieschke, D. Grail, D. Metcalf, G. Hodgson, J. A. Gall, D. W. Maher, J. Cebon, V. Sinickas, and A. R. Dunn. 1994. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl. Acad. Sci. USA 91: 5592-5596.
49. Spight, D., B. Trapnell, B. Zhao, P. Berclaz, and T. P. Shanley. 2008. Granulocyte-macrophage-colony-stimulating factor-dependent peritoneal macrophage responses determine survival in experimentally induced peritonitis and sepsis in mice. Shock 30: 434-442.
50. Seymour, J. F. 2006. Extra-pulmonary aspects of acquired pulmonary alveolar proteinosis as predicted by granulocyte-macrophage colony-stimulating factor-deficient mice. Respirology 11(Suppl.): S16-S22.
51. LeVine, A. M., J. A. Reed, K. E. Kurak, E. Cianciolo, and J. A. Whitsett. 1999. GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection. J. Clin. Invest. 103: 563-569.
52. + regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res. 64: 8451-8455.
53. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. 9: 162-174.
54. Brys, L., A. Beschin, G. Raes, G. H. Ghassabeh, W. Noel, J. Brandt, F. Brombacher, and P. De Baetselier. 2005. Reactive oxygen species and 12/15-lipoxygenase contribute to the antiproliferative capacity of alternatively activated myeloid cells elicited during helminth infection. J. Immunol. 174: 6095-6104.